Multiple Sclerosis Outcomes (Cleveland State University)

Rebecca Webster
Jul 27, 2025 9:02:54 AM

Do you or someone you know have multiple sclerosis?

CIONIC and researchers at Cleveland State University are conducting a research study for adults with multiple sclerosis (MS).

Study Purpose

The study aims to understand the clinical impact of the Cionic Neural Sleeve1 for individuals diagnosed with MS using outcomes related to fatigue, spasticity, quality of life, and activity levels.

Ideal Candidates

Ideal candidates are those who...

• Have relapsing-remitting or progressive forms of MS
• Are an adult between the ages of 22 and 75
• Are willing to make 3 visits to Cleveland State University’s research lab
• Are able to walk at least 15 minutes throughout the day for 5 days per week, with or without assistive devices

You are not able to join if you…

• Have absent sensation or an inadequate response to stimulation in the impacted or more impacted leg
• Require an ankle foot orthosis (AFO)/knee ankle foot orthosis (KAFO) to walk
• Have a history of falls greater than once a week
• Have a malignant tumor, existing thrombosis, or fracture/dislocation in the impacted or more impacted leg
• Have implanted demand-type cardiac pacemakers or defibrillators

Participation in the study may take up to 18 weeks. The study will require volunteers to visit Cleveland State University’s research lab in Cleveland, Ohio on 3 occasions and take part in a walking program. The 12-week walking program requires participants to walk for at least 15 minutes per day for 5 days per week while wearing an activity monitor and the Cionic Neural Sleeve for a 6-week period. The 90-minute lab visits will require participants to complete assessments of spasticity, balance, walking, range of motion, and strength. Participants will also complete questionnaires about the impact of MS and their daily activity level. Participants will receive an Amazon gift card for each testing session completed.

Want more information?

You can reach the study team by email at trials@cionic.com.

Safety & COVID Precautions:

Your safety is our primary concern and we have implemented a safety and sterilization protocol in response to COVID-19. This includes:

• Pre and Post cleaning to disinfect all surfaces, common areas, and testing space
• Pre and Post cleaning to disinfect the Cionic Neural Sleeve, chairs, and railings (everything you would touch as a participant)
• The number of people allowed at the research site will be limited
• All people entering the site will be asked about any recent COVID exposures
• The research team will wear masks upon request by the participant to minimize exposure to communicable diseases

1 The Cionic Neural Sleeve is a Food and Drug Administration (FDA)-cleared Class 2 medical device.